BioCentury
ARTICLE | Company News

Amylin deal

October 14, 1996 7:00 AM UTC

AMLN acquired exclusive patent rights from discoverer John Eng to exendin, a potential drug for Types I and II diabetes that is found in the venom of the Gila monster lizard. In animal models, the com...